Breath of Life International Pharma Ltd
Quick facts
Marketed products
- A1 · Diabetes
A1 works by inhibiting the action of a specific enzyme. - A2 · Psychiatry
A2 is a medication that works by inhibiting the reuptake of norepinephrine, serotonin, and dopamine. - A3 · Cardiovascular
A3 is a medication that works by inhibiting the renin-angiotensin system. - A4 · Infectious Disease
A4 is a monoclonal antibody that targets the CD4 receptor. - A5 · Diabetes
A5 is a medication that works by inhibiting the action of a specific enzyme. - B4 · Psychiatry
B4 is a medication that works by inhibiting the action of a specific enzyme.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Breath of Life International Pharma Ltd portfolio CI brief
- Breath of Life International Pharma Ltd pipeline updates RSS
Frequently asked questions about Breath of Life International Pharma Ltd
What are Breath of Life International Pharma Ltd's marketed drugs?
Top marketed products include A1, A2, A3, A4, A5, B4.